Literature DB >> 33968629

Narrative review of the contemporary surgical treatment of unicuspid aortic valve disease.

Maria von Stumm1, Tatjana Sequeira-Gross1, Johannes Petersen1, Shiho Naito1, Lisa Müller1, Christoph Sinning2, Evaldas Girdauskas1.   

Abstract

Unicuspid aortic valve disease (UAVD) is a frequent and long-lasting challenge for adult congenital heart disease centers. UAVD patients become usually symptomatic in their twenties or thirties and require a surgical treatment plan which should respect their complete lifespan combined with an adequate quality of life. Unfortunately, all current surgical strategies of congenital aortic valve disease bear some important limitations: (I) Aortic valve replacement using bioprosthetic valves is associated with early structural degeneration and leads frequently to re-operations. (II) Mechanical valves are commonly associated with lifelong risk of severe bleeding due to oral anticoagulation. (III) Using a pulmonary autograft (i.e., Ross procedure) for aortic valve replacement is associated with excellent long-term results in non-elderly patients. However, failure of pulmonary autograft or pulmonary homograft may require re-operations. (IV) Aortic valve repair or Ozaki procedure is only performed in a few heart centers worldwide and is associated with a limited reproducibility and early patch degeneration, suture dehiscence or increased risk of endocarditis. In contrast to degenerative tricuspid aortic valve disease, UAVD remains relatively understudied and reports on UAVD treatment are rare and usually limited to retrospective single-center observations. For this review, we searched PubMed for papers in the English language by using the search words unicuspid aortic valve, congenital aortic valve, Ross procedure, Ozaki procedure, aortic valve repair, mechanical/bioprosthetic aortic replacement, homograft. We read the abstracts of relevant titles to confirm their relevance, and the full papers were then extracted. References from extracted papers were checked for additional relevant reports. This review summarizes current surgical treatment strategies for UAVD including aortic valve replacement using bioprosthetic or mechanical valves, homografts, pulmonary autografts (i.e., Ross procedure) and aortic valve repair techniques for UAV. Furthermore, Ozaki procedure will be discussed. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Ross procedure; Unicuspid aortic valve disease (UAVD); aortic valve repair; congenital aortic valve disease

Year:  2021        PMID: 33968629      PMCID: PMC8102273          DOI: 10.21037/cdt-20-814

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  85 in total

1.  Challenges of coronary angiography and intervention in patients previously treated by TAVI.

Authors:  Johannes Blumenstein; Won-Keun Kim; Christoph Liebetrau; Luise Gaede; Joerg Kempfert; Thomas Walther; Christian Hamm; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2015-02-27       Impact factor: 5.460

2.  Aortic valve construction using pericardial tissue: short-term single-centre outcomes.

Authors:  Fanar Mourad; Sharaf-Eldin Shehada; Juri Lubarski; Maria Serrano; Ender Demircioglu; Daniel Wendt; Heinz Jakob; Jaroslav Benedik
Journal:  Interact Cardiovasc Thorac Surg       Date:  2019-02-01

3.  Aortic valve repair-lessons to be learned.

Authors:  Johannes Petersen; Evaldas Girdauskas
Journal:  Ann Transl Med       Date:  2017-09

4.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

5.  Rethinking the ross procedure in adults.

Authors:  T Brett Reece; Karl F Welke; Sean O'Brien; Maria V Grau-Sepulveda; Frederick L Grover; James S Gammie
Journal:  Ann Thorac Surg       Date:  2013-09-23       Impact factor: 4.330

6.  Prosthesis-patient mismatch after aortic valve replacement: impact of age and body size on late survival.

Authors:  Marc R Moon; Michael K Pasque; Nabil A Munfakh; Spencer J Melby; Jennifer S Lawton; Nader Moazami; John E Codd; Traves D Crabtree; Hendrick B Barner; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

Review 7.  Unicuspid aortic valve in children: a systematic review spanning four decades.

Authors:  Farouk Mookadam; Venkata R Thota; Ana Maria Garcia Lopez; Usha R Emani; Abdul J Tajik
Journal:  J Heart Valve Dis       Date:  2010-11

8.  Aortic Valve Repair of a Stenotic Unicuspid Aortic Valve in Young Patients.

Authors:  Adrian Kolesar; Tomas Toporcer; Milan Bajmoczi; Jan Luczy; Peter Candik; Frantisek Sabol
Journal:  Ann Thorac Surg       Date:  2018-01-31       Impact factor: 4.330

9.  Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.

Authors:  Andrew B Goldstone; Peter Chiu; Michael Baiocchi; Bharathi Lingala; William L Patrick; Michael P Fischbein; Y Joseph Woo
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

10.  Comparison of biomechanical and structural properties between human aortic and pulmonary valve.

Authors:  Peteris Stradins; Romans Lacis; Iveta Ozolanta; Biruta Purina; Velta Ose; Laila Feldmane; Vladimir Kasyanov
Journal:  Eur J Cardiothorac Surg       Date:  2004-09       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.